Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer

doi:10.5317/wjog.v2.i4.143

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6565)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

516

HTML

3529

Figures (1-6)

205

Tables (1-1)

182

Sum=4432

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1141

Download

992

Sum=2133

Nov 10, 2013 (publication date) through Sep 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Obstetrics and Gynecology

ISSN

2218-6220

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Obstet Gynecol. Nov 10, 2013; 2(4): 143-152
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.143

Full Size Figure Download Figure

Figure 4 Doxorubicin levels in tumor nodules, normal adjacent tissues, peritoneal fluid and plasma during hyperthermic intraperitoneal peroperative chemotherapy over 90 min with 15 mg/m² doxorubicin intraperitoneal administration. Modified from Van der Speeten et al[32].

Citation: Speeten KVD, Stuart AO, Sugarbaker PH. Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer. World J Obstet Gynecol 2013; 2(4): 143-152
URL: https://www.wjgnet.com/2218-6220/full/v2/i4/143.htm
DOI: https://dx.doi.org/10.5317/wjog.v2.i4.143